We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Annals of Pharmacy Practice and Pharmacotherapy

2024 Volume 4

Evaluation of Antibiotic Use and Financial Costs in University Hospital Intensive Care Units


, , , , , , ,
  1. Faculty of Medicine and Pharmacy, Doctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.
  2. Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.
  3. Department of Psycho-Neurosciences and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.
  4. Department of Surgical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.
Abstract

Intensive care units (ICUs) are the primary target for antibiotic consumption monitoring due to their high antibiotic usage. Antimicrobial resistance (AMR) is a major global public health concern. We conducted a five-year, monocentric, retrospective, and observational study to assess the use and cost of antibiotics in the intensive care units at the Oradea County Emergency Clinical Hospital in Romania. The amount was expressed in DDD/100 patient days, and the prescription antibiotic’s cost was in EUR. Half of the top ten antibiotics prescribed, or 84.81% of the total, were ceftriaxone and amoxicillin/clavulanic acid. Contrary to popular belief, fewer antibiotics are classified as access, and most are classified as WHO Watch. The most expensive antibiotic therapy prescriptions in the intensive care units were for ceftazidime/avibactam, cefoperazone/sulbactam, colistin, meropenem, tigecycline, ceftriaxone, amoxicillin/clavulanic acid, moxifloxacin, ertapenem, vancomycin, linezolid, ciprofloxacin, and piperacillin/tazobactam. Medication costs for ceftriaxone, amoxicillin/clavulanic acid, ertapenem, and piperacillin/tazobactam stayed mostly constant, whereas meropenem, tigecycline, vancomycin, moxifloxacin, and ciprofloxacin exhibited an upward trend. Our findings shed light on different aspects of antibiotic misuse, enabling cost-cutting solutions and a significant step towards the rationalisation of antibiotic use.


How to cite this article
Vancouver
Hodoșan V, Zaha DC, Daina LG, Tîrb AM, Mărcuț LF, Mohan AG, et al. Evaluation of Antibiotic Use and Financial Costs in University Hospital Intensive Care Units. Ann Pharm Pract Pharmacother. 2024;4:57-64. https://doi.org/10.51847/YPGFjKNDi2
APA
Hodoșan, V., Zaha, D. C., Daina, L. G., Tîrb, A. M., Mărcuț, L. F., Mohan, A. G., Cotrău, P., & Daina, C. M. (2024). Evaluation of Antibiotic Use and Financial Costs in University Hospital Intensive Care Units. Annals of Pharmacy Practice and Pharmacotherapy, 4, 57-64. https://doi.org/10.51847/YPGFjKNDi2
Articles
Comparative Evaluation of Oral Wound Dressing Materials: A Comprehensive Clinical Review
Annals of Pharmacy Practice and Pharmacotherapy
Vol 4 , 2024 | Maria Pia Ferraz
The Role of ABC Transporters in Ciprofloxacin Resistance of E. coli ST131
Annals of Pharmacy Practice and Pharmacotherapy
Vol 1 , 2021 | Alireza Ebadi Tabrizi
Development of an RP-HPLC Method for Dapagliflozin and Metformin HCL Analysis
Annals of Pharmacy Practice and Pharmacotherapy
Vol 1 , 2021 | Khagga Bhavyasri
Inequities in Antiviral Therapy for Diabetic Individuals Affected by COVID-19
Annals of Pharmacy Practice and Pharmacotherapy
Vol 3 , 2023 | Andreea Fitero
Optimizing Diagnosis and Treatment of Congestive Heart Failure in Primary Health Settings
Annals of Pharmacy Practice and Pharmacotherapy
Vol 2 , 2022 | Frans H Rutten
Evaluation of Antibiotic Use and Financial Costs in University Hospital Intensive Care Units
Annals of Pharmacy Practice and Pharmacotherapy
Vol 4 , 2024 | Viviana Hodoșan
Comparative Evaluation of Oral Wound Dressing Materials: A Comprehensive Clinical Review
Annals of Pharmacy Practice and Pharmacotherapy
Vol 4 , 2024 | Maria Pia Ferraz
Evaluation of Side Effects Following COVID-19 Vaccination in Saudi Arabia’s General Population
Annals of Pharmacy Practice and Pharmacotherapy
Vol 4 , 2024 | Maha Mahfouz Bakhuraysah

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.